RankAlpha logo
Back to Rankings

BIO.B

Bio-Rad LaboratoriesB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The bull case is that the guide cut and first-quarter disruption reset expectations enough for modest upside if academic demand stabilizes, Middle East disruption eases, and ddPCR/diagnostics execution holds; Bio-Rad also still had $1.56 billion of cash, cash equivalents and short-term investments at March 31, 2026 and remained active on buybacks [#10Q-2026-05-01].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Bio-Rad classified $400 million of 3.3% senior notes due March 2027 as current, and any refinancing could occur at higher rates even though liquidity appears sufficient [#10Q-2026-05-01].
Momentum
73
Value
64
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $270.00 · Bull $320.00 · Bear $220.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $325.00
Why
Momentum73 · Δ7d -
Value64 · Δ7d -0.3
Sentiment37 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
73
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
64
32% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-1.1
Sentiment
37
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 72.8 / Value 63.6 / Sentiment 36.5

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$8.23B
Beta
1.18
Shares Out
26.97M
P/E (TTM)
27.2
P/S (TTM)
3.38
P/FCF (TTM)
25.65
Rev YoY
+0.5%
EPS YoY
-154.4%
Gross Margin
+52.4%
Op Margin
+8.5%
Net Debt
-$462.9M
Current Ratio
5.44
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology